CLINICAL_TRIALS
trial_result
· 2011-07-22
Clinical Trial Update: Treatment With Infliximab in a Medical Setting (Study P05587) [Phase 4]
Summary
Phase 4 trial evaluating infliximab for Crohn's disease was terminated; results were posted in 2011.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Merck Sharp & Dohme LLC | Conditions: Crohn's Disease | Phase 4 | Status: TERMINATED | Results posted: 2011-07-22